These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21306034)

  • 1. Disease remission the goal of therapy in rheumatoid arthritis.
    Nisar MK; Ostör AJ
    Practitioner; 2010 Dec; 254(1735):17-21, 2. PubMed ID: 21306034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
    Sesin CA; Bingham CO
    Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol.
    Quinn MA; Green MJ; Marzo-Ortega H; Proudman S; Karim Z; Wakefield RJ; Conaghan PG; Emery P
    Arthritis Rheum; 2003 Nov; 48(11):3039-45. PubMed ID: 14613264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression in early rheumatoid arthritis.
    Combe B
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):59-69. PubMed ID: 19233046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term impact of delay in assessment of patients with early arthritis.
    van der Linden MP; le Cessie S; Raza K; van der Woude D; Knevel R; Huizinga TW; van der Helm-van Mil AH
    Arthritis Rheum; 2010 Dec; 62(12):3537-46. PubMed ID: 20722031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
    Svensson B; Boonen A; Albertsson K; van der Heijde D; Keller C; Hafström I
    Arthritis Rheum; 2005 Nov; 52(11):3360-70. PubMed ID: 16255010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to consultation and disease-modifying antirheumatic drug treatment of patients with rheumatoid arthritis--northern Alberta perspective.
    Nanji JA; Choi M; Ferrari R; Lyddell C; Russell AS
    J Rheumatol; 2012 Apr; 39(4):707-11. PubMed ID: 22337235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment and management of rheumatoid arthritis.
    Haraoui B
    J Rheumatol Suppl; 2009 Jun; 82():2-10. PubMed ID: 19509324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the use of conventional disease-modifying antirheumatic drugs in the management of rheumatoid arthritis.
    Feely MG; O'Dell JR
    Curr Opin Rheumatol; 2010 May; 22(3):316-20. PubMed ID: 20190639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary use of disease-modifying drugs in the management of patients with early rheumatoid arthritis in Norway.
    Nikolaisen C; Kvien TK; Mikkelsen K; Kaufmann C; Rødevand E; Nossent JC
    Scand J Rheumatol; 2009; 38(4):240-5. PubMed ID: 19229766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory arthritis: an overview for primary care physicians.
    Brent LH
    Postgrad Med; 2009 Mar; 121(2):148-62. PubMed ID: 19332973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unmet needs in rheumatoid arthritis.
    Bykerk V
    J Rheumatol Suppl; 2009 Jun; 82():42-6. PubMed ID: 19509330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to treatment for new patients with rheumatoid arthritis in a major metropolitan city.
    Jamal S; Alibhai SM; Badley EM; Bombardier C
    J Rheumatol; 2011 Jul; 38(7):1282-8. PubMed ID: 21572157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early rheumatoid arthritis: strategies for prevention and management.
    Combe B
    Best Pract Res Clin Rheumatol; 2007 Feb; 21(1):27-42. PubMed ID: 17350542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of rheumatoid arthritis.
    Rindfleisch JA; Muller D
    Am Fam Physician; 2005 Sep; 72(6):1037-47. PubMed ID: 16190501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early rheumatoid arthritis -- is there a window of opportunity?
    Cush JJ
    J Rheumatol Suppl; 2007 Nov; 80():1-7. PubMed ID: 17985417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic strategies in early rheumatoid arthritis.
    Smolen JS; Aletaha D; Machold KP
    Best Pract Res Clin Rheumatol; 2005 Feb; 19(1):163-77. PubMed ID: 15588977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis.
    Hernández-García C; Vargas E; Abásolo L; Lajas C; Bellajdell B; Morado IC; Macarrón P; Pato E; Fernández-Gutiérrez B; Bañares A; Jover JA
    J Rheumatol; 2000 Oct; 27(10):2323-8. PubMed ID: 11036824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advance and unmet need of health care for patients with rheumatoid arthritis in the German population--results from the German Rheumatoid Arthritis Population Survey (GRAPS).
    Westhoff G; Schneider M; Raspe H; Zeidler H; Runge C; Volmer T; Zink A
    Rheumatology (Oxford); 2009 Jun; 48(6):650-7. PubMed ID: 19321515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.